⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL28073066 | 0.87 | FFAR3 (0.42) | — | |
| SCHEMBL71769 | 0.80 | TSHR (0.35) | — | |
| SCHEMBL28647980 | 0.79 | CA4 (0.40) | — | |
| SCHEMBL7605280 | 0.79 | — | — | |
| SCHEMBL285627 | 0.77 | CA4 (0.48) | — | |
| SCHEMBL10563126 | 0.77 | CA4 (0.48) | — | |
| SCHEMBL368535 | 0.74 | — | — | |
| SCHEMBL27473070 | 0.74 | CA4 (0.46) | — | |
| SCHEMBL9619452 | 0.74 | CA4 (0.46) | — | |
| SCHEMBL1643232 | 0.74 | CA4 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4499 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1659178-B1 | A process for the purification or production of a MAGE protein | GLAXOSMITHKLINE BIOLOG SA (BE) | 2010-03-31 | — | — | EP | claimed |
| CN-1026899-C | Preparation method of flocculation-scale inhibitor for sugar | SOUTH CHINA SCIENCE AND TECHNO (CN) | 1994-12-07 | — | — | CN | claimed |
| CN-1039060-A | The preparation method of flocculent dirt-separating agent for sugar refining | SOUTH CHINA SCIENCE & TECHNOLO (CN) | 1990-01-24 | — | — | CN | claimed |
| EP-4748862-A2 | HETERODIMERIC PROTEINS | Xencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3620473-B1 | NOVEL HETERODIMERIC PROTEINS | XENCOR INC (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3865514-B9 | BISPECIFIC ANTIBODY BINDING DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-12630650-B2 | Engineered IgA antibodies and methods of use | TIGATX, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260132199-A1 | ANTIBODY CONSTRUCTS FOR DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4741424-A2 | FC VARIANTS WITH ALTERED BINDING TO FCRN | Xencor, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| CN-122029189-A | Anti-SARS-CoV-2 spike (S) antibodies and their use in treatment COVID-19 | 诺瓦瓦克斯股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-3817770-B1 | ANTI-STEAP1 ANTIGEN-BINDING PROTEIN | AMGEN INC (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-0391088-A2 | Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy | CENTER FOR BLOOD RESEARCH LABORATORIES, INC. (US) | 1990-10-10 | — | — | EP | disclosed |
| WO-1990010453-A1 | USE OF INTERCELLULAR ADHESION MOLECULES, AND THEIR BINDING LIGANDS IN THE TREATMENT OF ASTHMA | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1990-09-20 | — | — | WO | disclosed |
| EP-0387701-A1 | Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma | Boehringer Ingelheim Pharmaceuticals Inc. (US) | 1990-09-19 | — | — | EP | disclosed |
| EP-0387668-A1 | Intercellular adhesion molecule - 2 and its binding ligands | CENTER FOR BLOOD RESEARCH LABORATORIES, INC. (US) | 1990-09-19 | — | — | EP | disclosed |
| WO-1990007572-A1 | HUMAN DNase | GENENTECH, INC. (US) | 1990-07-12 | — | — | WO | disclosed |
| EP-0362272-A1 | METHOD AND COMPOSITIONS FOR MAKING ACSF AND ACSF ANTAGONISTS. | GENENTECH INC (US) | 1990-04-11 | — | — | EP | disclosed |
| CN-1039060-A | The preparation method of flocculent dirt-separating agent for sugar refining | SOUTH CHINA SCIENCE & TECHNOLO (CN) | 1990-01-24 | — | — | CN | disclosed |
| WO-1989012678-A1 | PURIFIED UBIQUITIN HYDROLASE, DNA SEQUENCES ENCODING SAME, AND ITS USE IN RECOVERING POLYPEPTIDES | GENENTECH, INC. (US) | 1989-12-28 | — | — | WO | disclosed |
| WO-1988009376-A1 | METHOD AND COMPOSITIONS FOR MAKING ACSF AND ACSF ANTAGONISTS | GENENTECH, INC. (US) | 1988-12-01 | — | — | WO | disclosed |